HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ji Hoon Jeong Selected Research

ginsenoside Re

7/2021Ginsenoside Re Protects against Serotonergic Behaviors Evoked by 2,5-Dimethoxy-4-iodo-amphetamine in Mice via Inhibition of PKCδ-Mediated Mitochondrial Dysfunction.
12/2017Ginsenoside Re protects against phencyclidine-induced behavioral changes and mitochondrial dysfunction via interactive modulation of glutathione peroxidase-1 and NADPH oxidase in the dorsolateral cortex of mice.
8/2015Ginsenoside Re protects methamphetamine-induced mitochondrial burdens and proapoptosis via genetic inhibition of protein kinase C δ in human neuroblastoma dopaminergic SH-SY5Y cell lines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ji Hoon Jeong Research Topics

Disease

49Neoplasms (Cancer)
01/2020 - 01/2005
31Inflammation (Inflammations)
04/2022 - 06/2013
20Insulin Resistance
01/2022 - 01/2017
12Mitochondrial Diseases (Mitochondrial Disease)
07/2021 - 02/2009
8Cognitive Dysfunction
01/2022 - 06/2013
7Obesity
01/2022 - 11/2014
6Neuroinflammatory Diseases
01/2021 - 01/2016
6Seizures (Absence Seizure)
04/2016 - 06/2003
5Non-alcoholic Fatty Liver Disease
12/2021 - 01/2018
5Parkinson Disease (Parkinson's Disease)
07/2021 - 09/2013
5Hyperlipidemias (Hyperlipidemia)
12/2020 - 11/2014
5Ischemic Stroke
06/2020 - 10/2014
5Hypoxia (Hypoxemia)
04/2019 - 09/2006
5Myocardial Infarction
12/2016 - 06/2013
4Hyperthermia
08/2021 - 01/2015
4Schizophrenia (Dementia Praecox)
02/2021 - 10/2016
4Ischemia
12/2016 - 09/2006
3Cicatrix (Scar)
07/2022 - 06/2012
3Rheumatoid Arthritis
01/2022 - 10/2014
3Wounds and Injuries (Trauma)
01/2022 - 09/2006
3Mania (Manias)
12/2021 - 01/2020
3Melanoma (Melanoma, Malignant)
01/2020 - 12/2018
3Atherosclerosis
01/2020 - 05/2012
3Breast Neoplasms (Breast Cancer)
11/2018 - 01/2015
3Myocardial Ischemia (Ischemic Heart Diseases)
12/2016 - 08/2014
3Infarction (Infarctions)
12/2016 - 06/2013
3Reperfusion Injury
07/2015 - 06/2013
3Ovarian Neoplasms (Ovarian Cancer)
01/2012 - 12/2003
2Stomach Neoplasms (Stomach Cancer)
07/2022 - 10/2018
2Neoplasm Metastasis (Metastasis)
07/2022 - 08/2005
2Osteoarthritis
01/2022 - 01/2021

Drug/Important Bio-Agent (IBA)

34Small Interfering RNA (siRNA)IBA
12/2021 - 09/2006
15PalmitatesIBA
05/2022 - 01/2017
14Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2019 - 08/2005
11Pharmaceutical PreparationsIBA
04/2022 - 01/2012
11PolyethyleneimineIBA
01/2020 - 01/2005
10LipidsIBA
01/2022 - 11/2014
10PolymersIBA
03/2021 - 05/2009
9Therapeutic UsesIBA
01/2022 - 10/2013
9DNA (Deoxyribonucleic Acid)IBA
08/2021 - 06/2010
9Deoxycholic Acid (Sodium Deoxycholate)IBA
04/2019 - 05/2012
9MicellesIBA
01/2018 - 12/2003
8Proteins (Proteins, Gene)FDA Link
07/2022 - 09/2006
8Insulin (Novolin)FDA Link
04/2022 - 09/2014
8Glutathione (Reduced Glutathione)IBA
01/2021 - 01/2015
7LigandsIBA
11/2018 - 01/2005
6AntioxidantsIBA
01/2022 - 08/2011
6Methamphetamine (Desoxyn)FDA LinkGeneric
07/2021 - 01/2015
6Phosphatidylcholines (Phosphatidylcholine)IBA
11/2020 - 06/2013
6Peptides (Polypeptides)IBA
08/2020 - 11/2008
5Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 10/2013
5Cocaine (Cocaine HCl)IBA
11/2020 - 04/2016
5LipopolysaccharidesIBA
01/2020 - 06/2013
5Interleukin-6 (Interleukin 6)IBA
11/2019 - 06/2013
510,17- dihydroxydocosa- 4,7,11,13,15,19- hexaenoic acidIBA
10/2019 - 01/2017
5Hyaluronic Acid (Hyaluronan)IBA
11/2015 - 10/2014
5Ethylene Glycol (Monoethylene Glycol)IBA
11/2015 - 07/2005
5PolyelectrolytesIBA
11/2008 - 01/2005
4CytokinesIBA
01/2022 - 06/2013
4Cholinergic Agents (Cholinergics)IBA
01/2022 - 06/2013
4NADPH Oxidases (NAD(P)H oxidase)IBA
05/2021 - 01/2016
4VaccinesIBA
01/2021 - 12/2018
4AMP-Activated Protein KinasesIBA
12/2020 - 01/2017
4Bile Acids and Salts (Bile Acids)IBA
01/2020 - 02/2014
4AntigensIBA
04/2019 - 04/2018
4Doxorubicin (Adriamycin)FDA LinkGeneric
04/2019 - 01/2012
4Fatty Acids (Saturated Fatty Acids)IBA
10/2018 - 01/2017
4Kainic Acid (Kainate)IBA
07/2015 - 02/2009
3Biomarkers (Surrogate Marker)IBA
07/2022 - 01/2018
3CollagenIBA
07/2022 - 01/2020
3AcidsIBA
01/2022 - 04/2011
3Sirtuin 1IBA
12/2021 - 10/2019
3Dopamine (Intropin)FDA LinkGeneric
08/2021 - 11/2015
3ginsenoside ReIBA
07/2021 - 08/2015
3EnzymesIBA
02/2021 - 10/2015
3Kynurenic Acid (Kynurenate)IBA
01/2021 - 01/2019
3DNA VaccinesIBA
01/2020 - 12/2018
3Glucose (Dextrose)FDA LinkGeneric
11/2019 - 01/2017
3Heme Oxygenase-1IBA
04/2019 - 01/2017
3Nitric Oxide (Nitrogen Monoxide)FDA Link
03/2018 - 02/2006
3Coloring Agents (Dyes)IBA
02/2018 - 10/2014
3CarbonIBA
02/2018 - 03/2015
3Antisense OligonucleotidesIBA
01/2018 - 09/2011
3Docosahexaenoic AcidsIBA
01/2018 - 01/2017
3Phencyclidine (Angel Dust)IBA
01/2018 - 10/2016
3trimethyltinIBA
11/2017 - 08/2011
3SolutionsIBA
01/2017 - 10/2013
3glycol-chitosanIBA
01/2017 - 01/2015
3GinsenosidesIBA
12/2015 - 01/2009
3Receptor for Advanced Glycation End ProductsIBA
11/2015 - 08/2014
3Folic Acid (Vitamin M)FDA LinkGeneric
01/2007 - 01/2005
2capmatinibIBA
04/2022 - 01/2021
2HydrogelsIBA
01/2022 - 01/2020
2valdecoxib (Bextra)FDA Link
01/2022 - 01/2021
2patchouli alcoholIBA
12/2021 - 01/2021
2apatinibIBA
09/2021 - 01/2017

Therapy/Procedure

26Therapeutics
12/2021 - 09/2006
4Immunotherapy
01/2020 - 12/2018
4Drug Therapy (Chemotherapy)
11/2018 - 03/2012
3Photothermal Therapy
02/2018 - 08/2015